India to Mexico: Bevacizumab Export Trade Route

The India to Mexico Bevacizumab corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $1.7M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 98% of all export value, reflecting the consolidated nature of India's bevacizumab manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $129.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with bevacizumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #13 among India's top bevacizumab export destinations globally.

On the import side, key buyers of Indian bevacizumab in Mexico include ZYDUS PHARMACEUTICALS M?XICO S.A. D, TO THE ORDER OF,, TOTAL SHIPPING SA DE CV , and 1 others. ZYDUS PHARMACEUTICALS M?XICO S.A. D is the single largest importer with 3 shipments valued at $1.7M USD.

India's bevacizumab exports to Mexico are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Mexico benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, MEDINEX HEALTHCARE, MYGENIC HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $129.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as abevmy 400 mg inj (bevacizumab) and harmless goods:bevacizumab 400(abevmy 400),pack:1vial, suggesting that buyers in Mexico tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ZYDUS PHARMACEUTICALS M?XICO S.A. D is the largest importer with 3 shipments worth $1.7M USD — representing 98% of all bevacizumab imports from India on this route.